From Financial Post · GlobeNewswire · · 1m 50s
Circle CVI Joins EXIT-CVD Consortium for European Heart Health
Circle CVI joins EXIT-CVD research consortium to advance imaging-informed, personalized cardiovascular care across Europe.
In brief
Circle CVI joins EXIT-CVD research consortium to advance imaging-informed, personalized cardiovascular care across Europe. Circle CVI joins EXIT-CVD, a five-year EU-funded project uniting 42 partners across 17 countries to conduct 22 clinical studies with 14,000+ patients for early cardiovascular disease intervention…
EXIT-CVD Project Launch
Circle CVI joins EXIT-CVD, a five-year research project uniting 42 public and private partners across 17 countries.
Project Goals
The project aims to help cardiac patients avoid deterioration through early, personalized interventions delivered across the cardiac care journey.
Patient Enrollment
First patients will be enrolled this month with 22 clinical studies involving 14,000+ patients across Europe.
Funding Details
With a total budget of EUR 27.6 million, the project is co-funded by the European Union Innovative Health Initiative and industry partners.
Project Coordinator
Professor Pim van der Harst, Project Coordinator of EXIT-CVD, states the goal is to exit the disease continuum before it’s too late.
Cardiology Chief
Robin Nijveldt, Chief of Cardiology at UMC Utrecht, emphasizes building a holistic view of patient experience for cardiac care.
Three Exit Points
The project focuses on early detection, personalized risk assessment, and advanced therapies to support recovery in later-stage disease.
Equity by Design
The project embeds implementation science and equity-by-design principles to ensure solutions are scalable and accessible to all populations.
Circle CVI Expertise
Circle CVI brings AI-enabled cardiovascular image analysis expertise through its cvi42 platform for clinical decision-making.
Clinical Studies
The project includes six clinical studies: CARDIO-CAM, LEADER-PAD, REMODEL-HF, GUIDANCE-PCCT, NOTIFY-2, and others.
Partnership Scope
The consortium comprises 42 partner organizations from 17 countries including hospitals, universities, and healthcare companies.
Funding Mechanism
The project is supported by the Innovative Health Initiative Joint Undertaking under grant agreement No 101253160.
The key point
Circle CVI joins EXIT-CVD, a five-year EU-funded project uniting 42 partners across 17 countries to conduct 22 clinical studies with 14,000+ patients for early cardiovascular disease intervention.
